Trending...
- Cold. Clean. Anywhere. Meet FrostSkin
- Apostle Margelee Hylton Announces the Release of Third Day Prayer
- Families Gain Clarity: Postmortem Pathology Expands Private Autopsy Services in St. Louis
Emerging biotech firm debuts "Science & Shield" initiative, bridging the gap between advanced medical research and immediate humanitarian relief for the Ozarks.
BRANSON, Mo. - PrAtlas -- Metavalis, a biotechnology innovator developing a proprietary Stealth Lipid Nanoparticle (LNP) platform, is proud to announce the launch of its "Science & Shield" humanitarian initiative. To mark this milestone, the company has partnered with community organizers to host a massive winter aid event in Branson.
While Metavalis is pioneering a new generation of stealth delivery systems to tackle rare and challenging diseases, the company's leadership maintains that advanced science must be paired with immediate community care.
"Our stealth LNP technology is designed to go where other treatments can't, solving the hardest problems in medicine," said Jordan Bekemeier, Founder and CEO of Metavalis. "But while we engineer solutions for the future, we also have to solve the problems right in front of us. That is why we are deploying resources today not just in the lab, but in the parking lot, handing out supplies to neighbors who are struggling."
More on PrAtlas
Event Details:
A Dual Layer of Support The event is a coordinated effort to provide comprehensive winter protection:
About Metavalis Metavalis is a biotechnology company focused on the treatment of rare and challenging diseases through its novel Stealth LNP platform. By engineering delivery vehicles that evade immune detection, Metavalis aims to unlock new possibilities in genetic medicine. The "Science & Shield" program represents the company's commitment to protecting human life at every level from the cellular to the community.
For more information, visit the Metavalis website.
While Metavalis is pioneering a new generation of stealth delivery systems to tackle rare and challenging diseases, the company's leadership maintains that advanced science must be paired with immediate community care.
"Our stealth LNP technology is designed to go where other treatments can't, solving the hardest problems in medicine," said Jordan Bekemeier, Founder and CEO of Metavalis. "But while we engineer solutions for the future, we also have to solve the problems right in front of us. That is why we are deploying resources today not just in the lab, but in the parking lot, handing out supplies to neighbors who are struggling."
More on PrAtlas
- Tri-State Area Entrepreneur Launches K-Chris: A Premium Digital Destination for Luxury Fragrances
- Why One American Manufacturer Builds BBQ Smokers to Aerospace Standards
- Diversified Roofing Solutions Strengthens Industry Leadership With Expanded Roofing Services Across South Florida
- ZRCalc™ Cinema Card Calculator Now Available for Nikon ZR Shooters
- Revolutionary Data Solution Transforms Health Insurance Underwriting Accuracy
Event Details:
- Date: Saturday, February 7, 2026
- Time: 12:00 PM – 3:00 PM CST
- Location: 993 Branson Hills Parkway, Branson, MO (Parking lot)
A Dual Layer of Support The event is a coordinated effort to provide comprehensive winter protection:
- The Davis Family will be distributing a massive supply of winter coats, hats, and heavy weather gear to protect against the cold.
- Metavalis will be distributing "Shield Kits" care packages containing non perishable food, first aid supplies (band aids, sanitizers), and hygiene essentials.
About Metavalis Metavalis is a biotechnology company focused on the treatment of rare and challenging diseases through its novel Stealth LNP platform. By engineering delivery vehicles that evade immune detection, Metavalis aims to unlock new possibilities in genetic medicine. The "Science & Shield" program represents the company's commitment to protecting human life at every level from the cellular to the community.
For more information, visit the Metavalis website.
Source: Metavalis Inc.
0 Comments
Latest on PrAtlas
- Florida Keys Visitors Can Save 15 Percent With KeysCaribbean's Advanced Booking Discount
- Sleep Basil Unveils Revamped Natural Latex Mattress Collection Page for Cooler, Cleaner, Better-Aligned Sleep
- Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
- FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP
- $2.7 Million 2025 Revenue; All Time Record Sales Growth; 6 Profitable Quarters for Homebuilding Industry: Innovative Designs (Stock Symbol: IVDN)
- CCHR: Decades of Warnings, Persistent Inaction; Studies Raise New Alarms on Psychiatric Drug Safety
- PRÝNCESS Builds Anticipation With "My Nerves" — A Girls-Girl Anthem
- Arbutus Medical Raises C$9.3M to Accelerate Growth of Surgical Workflow Solutions Outside the OR
- From Sleepless Nights to Sold-Out Drops: Catch Phrase Poet's First Year Redefining Motivational Urban Apparel
- Cold. Clean. Anywhere. Meet FrostSkin
- How Specialized Game Development Services Are Powering the Next Wave of Interactive Entertainment
- Don't Settle for a Lawyer Who Just Speaks Spanish. Demand One Who Understands Your Story
- Dan Williams Promoted to Century Fasteners Corp. – General Manager, Operations
- Ski Johnson Inks Strategic Deals with Three Major Food Chain Brands
- NIL Club Advances Agent-Free NIL Model as Oversight Intensifies Across College Athletics
- Atlanta Magazine Names Dr. Rashad Richey One of Atlanta's Most Influential Leaders in 2026 as the FIFA World Cup Approaches
- Apostle Margelee Hylton Announces the Release of Third Day Prayer
- Slotozilla Reports Strong Q4 Growth and Sigma Rome Success
- "Lights Off" and Laughs On: Joseph Neibich Twists Horror Tropes in Hilariously Demonic Fashion
- Families Gain Clarity: Postmortem Pathology Expands Private Autopsy Services in St. Louis



